id: NEW:telehealth_aud_treatment_access_to_NEW:aud_medication_coverage_duration
name: Telehealth AUD Treatment Access â†’ AUD Medication Coverage Duration
from_node:
  node_id: NEW:telehealth_aud_treatment_access
  node_name: Telehealth AUD Treatment Access
to_node:
  node_id: NEW:aud_medication_coverage_duration
  node_name: AUD Medication Coverage Duration
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Telehealth enables more frequent provider contact for medication management'
- 'Step 2: Reduced barriers to follow-up visits improve medication monitoring and adjustment'
- 'Step 3: Sustained provider engagement supports continued medication prescribing'
- 'Step 4: Longer medication coverage duration achieved through reduced structural barriers to care'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: P. Perumalswami et al. 2024. "Telehealth and delivery of alcohol use disorder treatment
    in the Veterans Health Administration.." https://doi.org/10.1111/acer.15305
  supporting_citations:
  - Additional citations require full-text access
  doi: 10.1111/acer.15305
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Receiving any AUD telehealth was associated with longer medication coverage days compared
  to only in-person care, indicating telehealth supports treatment continuity for pharmacotherapy
quantitative_effects:
  sample_size: 138619
spatial_variation:
  varies_by_geography: true
  variation_notes: Mixed-effects models adjusted for facility-level clustering, indicating geographic
    and facility-level variation in outcomes
moderators:
- name: gender
  direction: weakens
  strength: moderate
  description: Male patients were less likely to receive any telehealth-delivered AUD treatment
- name: opioid_use_disorder_comorbidity
  direction: weakens
  strength: moderate
  description: Patients with opioid use disorder were less likely to receive telehealth AUD treatment
- name: stimulant_use_disorder_comorbidity
  direction: weakens
  strength: moderate
  description: Patients with stimulant use disorder were less likely to receive telehealth AUD treatment
structural_competency:
  equity_implications: This mechanism highlights how healthcare delivery modality acts as a structural
    determinant of treatment duration. The association between telehealth and longer medication coverage
    suggests that in-person-only requirements create barriers that limit treatment duration. Medication
    treatment for AUD is evidence-based but underutilized; telehealth may address access barriers at the
    systems level.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.727924'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
